Deepak Shukla Selected Research

Deepak Shukla Research Topics

Disease

68	Infections 12/2022 - 10/2002
21	Herpes Simplex 04/2022 - 10/2002
16	Virus Diseases (Viral Diseases) 04/2022 - 04/2011
7	Inflammation (Inflammations) 12/2021 - 10/2004
5	Eye Infections 04/2022 - 09/2013
5	Neoplasms (Cancer) 12/2021 - 08/2006
4	COVID-19 09/2022 - 06/2020
3	Herpesviridae Infections (Herpesvirus Infection) 04/2022 - 12/2008
3	Disease Progression 01/2022 - 01/2021
3	Wounds and Injuries (Trauma) 01/2021 - 01/2017
3	Keratitis 01/2021 - 02/2015
2	Cytokine Release Syndrome 01/2022 - 01/2022
2	Herpes Genitalis (Genital Herpes) 01/2019 - 01/2016
2	Latent Infection 01/2019 - 04/2013
1	Osteonecrosis (Kienbock's Disease) 03/2022
1	Periapical Periodontitis (Apical Periodontitis) 01/2022
1	Periodontitis 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Neoplasm Metastasis (Metastasis) 03/2021
1	Corneal Opacity 01/2021
1	Herpetic Keratitis 10/2019
1	Pathologic Processes 02/2019
1	Melanoma (Melanoma, Malignant) 10/2018
1	Cytomegalovirus Infections (Inclusion Disease) 05/2015
1	Gastric Outlet Obstruction 10/2014
1	Multiple Sclerosis 04/2013
1	Iritis 04/2013

Drug/Important Bio-Agent (IBA)

17	Antiviral Agents (Antivirals)IBA 04/2022 - 08/2010
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2004
12	Heparitin Sulfate (Heparan Sulfate)IBA 01/2020 - 09/2005
9	Peptides (Polypeptides)IBA 10/2021 - 07/2011
8	CytokinesIBA 01/2022 - 04/2013
8	NectinsIBA 04/2013 - 10/2004
7	BX795IBA 04/2022 - 01/2018
7	heparanaseIBA 12/2021 - 04/2015
6	HCEIBA 12/2022 - 11/2010
6	VaccinesIBA 09/2022 - 04/2013
6	Acyclovir (Aciclovir)FDA LinkGeneric 04/2022 - 09/2013
6	Glycoproteins (Glycoprotein)IBA 02/2019 - 10/2002
5	EnzymesIBA 01/2021 - 11/2014
4	NucleosidesIBA 04/2022 - 06/2016
4	Zinc Oxide FDA Link 01/2019 - 12/2012
3	Biological ProductsIBA 12/2021 - 10/2002
3	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 04/2015
3	Protein Isoforms (Isoforms)IBA 11/2014 - 10/2002
3	Cytochalasin DIBA 01/2013 - 08/2008
2	Liposomes (Liposome)IBA 12/2022 - 01/2016
2	CarbonIBA 04/2022 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 12/2020 - 01/2019
2	Syndecan-1 (Syndecan 1)IBA 01/2020 - 04/2011
2	MicroRNAs (MicroRNA)IBA 05/2018 - 01/2018
1	BBV152 COVID-19 vaccineIBA 09/2022
1	COVID-19 VaccinesIBA 09/2022
1	ChAdOx1 nCoV-19IBA 09/2022
1	2-benzyl-3-formylpropanoic acid (BFP)IBA 03/2022
1	NexusIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Complement Inactivating AgentsIBA 01/2022
1	compstatinIBA 01/2022
1	CateninsIBA 12/2021
1	CholesterolIBA 12/2021
1	Antimicrobial PeptidesIBA 12/2021
1	HistatinsIBA 12/2021
1	sigma-2 receptorIBA 12/2021
1	TOR Serine-Threonine KinasesIBA 10/2021
1	Mechanistic Target of Rapamycin Complex 2IBA 10/2021
1	OligonucleotidesIBA 10/2021
1	Viral ProteinsIBA 10/2021
1	Virus ReceptorsIBA 01/2021
1	4-phenylbutyric acid (Buphenyl)FDA Link 12/2020
1	Carboxylic AcidsIBA 11/2020
1	PolymersIBA 11/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	ProdigiosinIBA 01/2020
1	Cell Surface ReceptorsIBA 02/2019
1	Cathepsin LIBA 12/2018
1	Enzyme Precursors (Zymogens)IBA 12/2018
1	matrigelIBA 10/2018
1	dimemorfan (AT 17)IBA 10/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	A-Form DNA (A-DNA)IBA 12/2017
1	Nucleotide AptamersIBA 12/2017
1	Glycoside Hydrolases (Endoglycosidases)IBA 09/2017
1	OxidesIBA 01/2017
1	MetalsIBA 01/2017
1	GalactosidasesIBA 01/2017
1	Anti-Infective Agents (Microbicides)IBA 01/2016
1	NF-kappa B (NF-kB)IBA 04/2015
1	Semaphorins (Semaphorin)IBA 02/2015
1	Capecitabine (Xeloda)FDA Link 10/2014
1	Myosin-Light-Chain KinaseIBA 01/2014
1	Nucleic Acid Synthesis InhibitorsIBA 05/2013

Therapy/Procedure

18	Therapeutics 01/2022 - 01/2012
2	Immunomodulation 12/2021 - 01/2021
2	Contact Lenses 01/2021 - 01/2016
1	Duration of Therapy 01/2019
1	Oncolytic Virotherapy 10/2018